Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

721 companies

Ticker ▴	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
AVPT	AvePoint, Inc. Services · Year ended 2025-12-31 · USD	$419.50M	$34.80M	8.3%	7.3%	26.9%	$0.15
AWCA	Awaysis Capital, Inc. Finance & Real Estate · Year ended 2026-06-30 · USD	$1.29M	-$2.59M	-201.1%	-44.8%	191.6%	-$0.01
AXG	Solowin Holdings, Ltd. Finance & Real Estate · Year ended 2026-03-31 · USD	$28.05M	-$13.29M	-47.4%	-52.8%	895.0%	-$0.11
AXON	Axon Enterprise, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.78B	$124.66M	4.5%	3.8%	33.5%	$1.51
AXSM	Axsome Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$638.50M	-$183.17M	-28.7%	-207.5%	65.5%	-$3.68
AZIO	Azio AI Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$5.94M	-$39.13M	-658.8%	n/a	217.6%	n/a
BA	Boeing Co Manufacturing · Year ended 2025-12-31 · USD	$89.46B	$2.23B	2.5%	41.0%	34.5%	$2.48
BBIO	BridgeBio Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$502.08M	-$732.94M	-146.0%	n/a	126.3%	-$3.78
BBNX	Beta Bionics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$100.25M	-$73.20M	-73.0%	-25.5%	53.9%	-$1.81
BCRD	BlueOne Technologies, Inc. Services · Year ended 2026-03-31 · USD	$260.0K	-$2.95M	n/m	-51.6%	136.1%	-$0.21
BCRX	BioCryst Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$874.84M	$263.86M	30.2%	n/a	94.1%	$1.21
BCYC	Bicycle Therapeutics PLC Manufacturing · Year ended 2025-12-31 · USD	$72.59M	-$218.96M	-301.7%	-35.9%	105.8%	-$3.16
BDAI	Biddance AI Systems, Inc. Services · Year ended 2025-12-31 · USD	$6.54M	$180.1K	2.8%	0.5%	125.0%	$0.02
BDPT	Bioadaptives, Inc. Manufacturing · Year ended 2025-12-31 · USD	$18.3K	-$1.56M	n/m	n/a	44.3%	-$0.15
BE	Bloom Energy Corp Manufacturing · Year ended 2025-12-31 · USD	$2.02B	-$87.14M	-4.3%	-11.3%	37.3%	-$0.37
BEAM	Beam Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$139.74M	-$79.99M	-57.2%	-6.5%	120.0%	-$0.81
BELFA	Bel Fuse Inc Manufacturing · Year ended 2025-12-31 · USD	$675.46M	$61.54M	9.1%	14.5%	26.3%	n/a
BETA	BETA Technologies, Inc. Manufacturing · Year ended 2025-12-31 · USD	$35.62M	-$745.87M	n/m	-41.0%	136.0%	-$12.85
BETR	Better Home & Finance Holding Co Finance & Real Estate · Year ended 2025-12-31 · USD	$164.87M	-$165.87M	-100.6%	-446.1%	52.0%	-$10.80
BG	Bunge Global SA Manufacturing · Year ended 2025-12-31 · USD	$70.33B	$816.00M	1.2%	4.7%	32.4%	$4.91
BGC	BGC Group, Inc. Finance & Real Estate · Year ended 2025-12-31 · USD	$2.94B	$154.96M	5.3%	13.5%	30.0%	$0.31
BGM	BGM Group Ltd. Manufacturing · Year ended 2025-09-30 · USD	$37.92M	-$19.94M	-52.6%	-5.1%	51.1%	-$0.18
BHF	Brighthouse Financial, Inc. Finance & Real Estate · Year ended 2025-12-31 · USD	$6.77B	$438.00M	6.5%	6.4%	43.2%	$5.71
BHIC	BioScience Health Innovations, Inc. Services · Year ended 2025-12-31 · USD	$5.69M	$642.1K	11.3%	43.5%	208.3%	$0.06
BHM	Bluerock Homes Trust, Inc. Finance & Real Estate · Year ended 2025-12-31 · USD	$68.73M	-$32.60M	-47.4%	-25.3%	36.9%	-$3.02

Rows per page: 2550 100